Tazemetostat is the world’s first orally administered, selective EZH2 (enhancer of zeste homolog 2) inhibitor approved for marketing, and it belongs to epigenetic targeted therapeutic agents.
Authentic
Guarantee
Fast Delivery
Privacy Copyright2024@ BIGBEAR All right reserved BIGBEAR



